Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-07

Clinical Trial Update: Do Probiotics Reduce The Risk Of Severe Necrotising Enterocolitis (NEC) In Infants Born Before 32 Weeks Gestation?

View source ↗

Summary

An Imperial College London trial is evaluating whether probiotic therapy can reduce the risk of severe necrotizing enterocolitis in infants born before 32 weeks…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotics

Snippet

Sponsor: Imperial College London | Conditions: Enterocolitis, Necrotizing | Status: ENROLLING_BY_INVITATION